Industry Briefs: May 7, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Company News
Almac has installed an Uhlmann high-speed blister line in its new US commercial packaging facility. Read More
Celsion has signed a long-term commercial-supply agreement with Zhejiang Hisun Pharmaceutical for the production of ThermoDox, a heat-activated liposomal encapsulation of doxorubicin. Read More
Evotec has signed a compound-management agreement with the US Environmental Protection Agency. The contract covers a period of five years and has a total value of up to EUR 7.7 million ($10 million). Read More
Grain Processing Corporation (GPC) has opened its new Solutions Center, located in the Technical Development Center at GPC headquarters in Muscatine, Iowa. Read More
Lorus Therapeutics and Genentech have signed a global intellectual property license agreement for IL-17E, a drug for treating cancer. Read More
Marina Biotech has announced a worldwide exclusive licensing agreement with Monsanto for Marina Biotech’s delivery and chemistry technologies. Read More
Pii has provided funding for hot-melt extrusion capabilities at the University of Mississippi. Read More
Sartorius Stedim Biotech and c-LEcta have signed a sales and distribution agreement for c-LEcta’s proprietary Serratia marcescens nuclease for biopharmaceutical applications. Read More
SGS Life Science Services has announced the availability of preformulation and formulation services at its laboratory in Lincolnshire, Illinois.
People News
Althea Technologies has appointed Kristin DeFife as director of biologics manufacturing and Jack Wright as vice-president of sales and marketing. Read More
Covance has announced several executive appointments. Read More
EMD Millipore has appointed Andrew Bulpin as head of the company’s process solutions business unit. Read More
GlaxoSmithKline named James Shannon chief medical officer, effective May 1, 2012. Read More
In other news, GlaxoSmithKline has appointed Lynn Elsenhans and Jing Ulrich to its board as nonexecutive directors, effective July 1, 2012. Read More
Is “right first time, every time” a pipedream for metabolite identification by LC-MS?
March 18th 2025The dream state If we lived in an ideal world, it would be possible to unambiguously identify metabolites using a single analytical experiment. This analytical technique would need to be efficient and easily generate the information needed from a routine assay that is also robust, enabling confident decision-making during drug discovery. At SCIEX, we believe that metabolite identification using the ZenoTOF 7600 system gets close to this dream state.
